Archive: Ross Marchand

Congress Must Axe Christmas Tree Tax
The Consumer Product Safety Commission has been having a field day regulating any and all festive lights under Santa’s sleigh.
An Alzheimer’s Cure May Be On the Horizon—But Only With Right-Sized Regulations
The FDA could and should be more open-minded in evaluating the evidence in its drug approval decisions.
An International Agency Could Erode American Liberties on U.S. Taxpayers’ Dime
Attorney-client privilege is a cornerstone of Western law and is worth preserving.
Did Midas Touch Medicare?
Despite its positive reputation, Medicare isn’t exactly a harbinger of health.
A Tale of Two Drug Approvals
The FDA has a unique responsibility to approve game-changing medications in a timely manner.
Germany Shows Universal Healthcare Is No Panacea
The government mandates, standardizes, and subsidizes care, and yet, struggling citizens still get subpar care.
America Needs Doctors in the Digital Domain
Seeing the doctor could be a twenty-minute Skype session, instead of a day-long ordeal.
Study Committee Delivers on Bold New Healthcare Plan
A truly market-based healthcare system would deliver the goods, but only if Congress passes bold reforms.
There’s a Lack of Expertise on Capitol Hill. That’s Okay.
In-house expertise often stymies genuine intellectual debate by giving a single analysis an official stamp of approval.
Faux Globalism Benefits No One
Large reductions in pollution tend to happen as economic freedom increases and businesses invest in large-scale efficiency improvements.